Sun Pharmaceutical Industries said on Tuesday that it has launched a new cough management formula, Chericof 12, in the country. The drug is India’s first prescription cough syrup that can relieve up to 12 hours, the Mumbai-based drug specialist company said in a statement. It added that it was manufactured using Polistirex technology for sustained release of drugs. Chericof 12 is approved for patients in the age group 6 years and older. “The Polistirex technology used in Chericof 12 helps improve patient compliance and avoid frequent dosing,” said Kirti Ganorkar, CEO of Sun Pharma India. Polistirex technology The Polistirex technology involves the complexation of two drugs, dextromethorphan hydrobromide and chlorpheniramine maleate, with a resin. The resin particles of the two drugs were added to the suspension to form Chericof 12. The complexation of the drug with polistirex not only provides sustained release, but also masks the bitter taste and makes it more palatable. The drug maker stated that Chericof 12 is a prescription product and can only be taken on the advice of a doctor. Sun Pharma is the world’s fourth largest professional generic drug company and India’s top pharmaceutical company.
News Source : Backtrack
